Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2003
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113387 Comprising Sasa albo-marginata (Bambooseae Sasa) extract; sulfur components
06/19/2003US20030113386 For countering or slowing down appearance of signs of ageing of skin
06/19/2003US20030113355 Nontoxic vernix compositions and method of producing
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113315 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
06/19/2003US20030113291 Biocidal polymers based on guanidine salts
06/19/2003US20030113287 Topical liquid composition for promoting hair growth and process of manufacturing thereof
06/19/2003US20030113284 Use of DHEA derivatives on keratinous substances
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469792A1 In vitro production of dendritic cells from cd14+ monocytes especially for the preparation of suspension, monolayer and three-dimensional cell and/or tissue models, and use of these models
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469000A1 Method for reducing acne or improving skin tone
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319407A1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
06/18/2003EP1319402A1 Ige production inhibitors
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318833A2 Compositions and methods for cell dedifferentiation and tissue regeneration
06/18/2003EP1318829A1 Angiogenic agents and their uses
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1318807A1 Photosensitizing ointment
06/18/2003EP1228075B1 Silicon compounds derived from ascorbic acid
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0868177B1 Drug delivery device
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424904A Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
06/18/2003CN1424903A Personal care articles comprising cationic polymer coacervate compositions
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424077A External used medicine for psoriasis
06/18/2003CN1424075A Chinese medicine for treating trichomadesis and preparation thereof
06/18/2003CN1424056A Ointment made of cupressceae leaves for treating burns
06/18/2003CN1424040A Medicine against human papilloma virus
06/18/2003CN1424038A Preparation process for minoxidil spraying agent for treating bald and phalacrosis
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1424020A Sun screener containing dibenzoyl methane derivative and amino substituted 2-hydroxy benzophenone derivative
06/18/2003CN1424018A San screener containing 1,3,5-triazine derivative, dibenzoylmethane derivative and amino substitued 2-hydroxy-benzene ketone derivative
06/18/2003CN1111423C Medicine for treating injury
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579978 Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579540 Administering bis/maltolato/oxovanadium for prophylaxis of tisssue injuries or traumas
06/12/2003WO2003048192A1 Novel peptides and medicinal uses thereof
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003047643A1 Controlled release therapeutic wound dressings
06/12/2003WO2003047637A1 Sterilizing tunnel for pharmaceutical containers
06/12/2003WO2003047633A2 Treatment of angiogenesis disorders using targeted nanoparticles
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047609A1 A topical anti-itch formulation and a process for the preparation thereof
06/12/2003WO2003047604A1 Use of selenite-containing compounds to be topically or buccally administered
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
1 ... 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 ... 1065